Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put as share price up
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Hims and Hers (HIMS) PT Raised to $21 at BofA Securities
February 20, 2025 5:18 AM ESTBofA Securities analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $21.00 (from $18.00) while maintaining a Underperform rating.
The analyst comments "HIMS observed sales per Bloomberg Second Measure (BSM) data grew 104% y/y in January and suggests GLP-1s... More
Hims and Hers (HIMS) PT Raised to $85 at BTIG
February 18, 2025 5:20 AM ESTBTIG analyst David Larsen raised the price target on Hims and Hers (NYSE: HIMS) to $85.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Shares of both Hims and Hers Health (HIMS, Buy, $85 PT) and LifeMD (LFMD, Buy, $12 PT) are... More
